Form 4: Alignment Healthcare Executive Hakan Kardes Sells 25,000 Shares
SEC Form 4 Filing
Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 25,000 shares of common stock on September 12, 2024, at a weighted-average price of $11.4821 per share.
Summary
- Hakan Kardes, the Chief Experience Officer of Alignment Healthcare, sold 25,000 shares of the company's common stock on September 12, 2024.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2024.
- The shares were sold at a weighted-average price of $11.4821, with individual prices ranging from $11.48 to $11.49.
- Following the transaction, Kardes directly owns 380,444 shares of Alignment Healthcare.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission (SEC).
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine transaction under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.
Industry Context
Executive stock sales are a common occurrence and can be for various personal financial planning reasons. It's important to consider the context of the sale, such as the executive's overall holdings and whether the sale was pre-planned under a 10b5-1 trading plan.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of adoption of Rule 10b5-1 plan |
| 09/12/2024 | Date of transaction (sale of shares) |
| 09/13/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.